Endogenous gasdermin activity is precisely regulated in vivo, as it contributes to the release of pro-inflammatory factors, whose dysregulation can cause autoinflammatory diseases, metabolic syndromes, acute and chronic inflammations66. This evidence concerns the gene GSDMA and metabolic syndrome.